FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2893470318> ?p ?o ?g. }

• W2893470318 endingPage "77" @default.
• W2893470318 startingPage "67" @default.
• W2893470318 abstract "Abstract Advanced glycation end products (AGEs) accumulate in tissues with aging and may influence age-related diseases. They can be estimated non-invasively by skin autofluorescence (SAF) using the AGE Reader™. Serum 25-hydroxyvitamin D 3 (25(OH)D 3 ) may inhibit AGEs accumulation through anti-oxidative and anti-inflammatory properties but evidence in humans is scarce. The objective was to investigate the association between serum 25(OH)D 3 and SAF in the population-based cohort study. Serum 25(OH)D 3 and other covariates were measured at baseline. SAF was measured on average 11.5 years later. Known risk factors for AGE accumulation such as higher age, BMI, and coffee intake, male sex, smoking, diabetes, and decreased renal function were measured at baseline. Linear regression models were adopted to explore the association between 25(OH)D 3 and SAF with adjustment for confounders. Interaction terms were tested to identify effect modification. The study was conducted in the general community. 2746 community-dwelling participants (age ≥ 45 years) from the Rotterdam Study were included. Serum 25(OH)D 3 inversely associated with SAF and explained 1.5% of the variance (unstandardized B = − 0.002 (95% CI[− 0.003, − 0.002]), standardized β = − 0.125), independently of known risk factors and medication intake. The association was present in both diabetics (B = − 0.004 (95% CI[− 0.008, − 0.001]), β = − 0.192) and non-diabetics (B = − 0.002 (95% CI[− 0.003, − 0.002]), β = − 0.122), both sexes, both smokers and non-smokers and in each RS subcohort. Serum 25(OH)D 3 concentration was significantly and inversely associated with SAF measured prospectively, also after adjustment for known risk factors for high SAF and the number of medication used, but the causal chain is yet to be explored in future studies. Clinical Trial Registry (1) Netherlands National Trial Register: Trial ID: NTR6831 ( http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=6831 ). (2) WHO International Clinical Trials Registry Platform: under shared catalogue number NTR6831 ( www.who.int/ictrp/network/primary/en/ )." @default.
• W2893470318 created "2018-10-05" @default.
• W2893470318 creator A5003599279 @default.
• W2893470318 creator A5031530236 @default.
• W2893470318 creator A5054662814 @default.
• W2893470318 creator A5057157877 @default.
• W2893470318 creator A5060705275 @default.
• W2893470318 creator A5067726769 @default.
• W2893470318 creator A5086356696 @default.
• W2893470318 date "2018-09-25" @default.
• W2893470318 modified "2023-10-08" @default.
• W2893470318 title "Serum 25-hydroxyvitamin D3 is associated with advanced glycation end products (AGEs) measured as skin autofluorescence: The Rotterdam Study" @default.
• W2893470318 cites W1511701404 @default.
• W2893470318 cites W1534918835 @default.
• W2893470318 cites W1966234811 @default.
• W2893470318 cites W1966328228 @default.
• W2893470318 cites W1968484794 @default.
• W2893470318 cites W1970516100 @default.
• W2893470318 cites W1985775184 @default.
• W2893470318 cites W1987515502 @default.
• W2893470318 cites W1987603842 @default.
• W2893470318 cites W1996895672 @default.
• W2893470318 cites W1997731534 @default.
• W2893470318 cites W2002616153 @default.
• W2893470318 cites W2021375120 @default.
• W2893470318 cites W2024416898 @default.
• W2893470318 cites W2030520431 @default.
• W2893470318 cites W2034124474 @default.
• W2893470318 cites W2047964022 @default.
• W2893470318 cites W2048197924 @default.
• W2893470318 cites W2048487111 @default.
• W2893470318 cites W2054221638 @default.
• W2893470318 cites W2059102250 @default.
• W2893470318 cites W2065974896 @default.
• W2893470318 cites W2068900191 @default.
• W2893470318 cites W2074794423 @default.
• W2893470318 cites W2074949061 @default.
• W2893470318 cites W2077034296 @default.
• W2893470318 cites W2085333075 @default.
• W2893470318 cites W2087698373 @default.
• W2893470318 cites W2088850537 @default.
• W2893470318 cites W2089878313 @default.
• W2893470318 cites W2098342740 @default.
• W2893470318 cites W2104735635 @default.
• W2893470318 cites W2132203967 @default.
• W2893470318 cites W2134064184 @default.
• W2893470318 cites W2136497849 @default.
• W2893470318 cites W2136647137 @default.
• W2893470318 cites W2137410358 @default.
• W2893470318 cites W2137927685 @default.
• W2893470318 cites W2163425767 @default.
• W2893470318 cites W2167798032 @default.
• W2893470318 cites W2310881502 @default.
• W2893470318 cites W2471300363 @default.
• W2893470318 cites W2559144644 @default.
• W2893470318 cites W2570140084 @default.
• W2893470318 cites W2593785051 @default.
• W2893470318 cites W2621152303 @default.
• W2893470318 cites W2766195635 @default.
• W2893470318 cites W2790228037 @default.
• W2893470318 doi "https://doi.org/10.1007/s10654-018-0444-2" @default.
• W2893470318 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6325991" @default.
• W2893470318 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30255328" @default.
• W2893470318 hasPublicationYear "2018" @default.
• W2893470318 type Work @default.
• W2893470318 sameAs 2893470318 @default.
• W2893470318 citedByCount "11" @default.
• W2893470318 countsByYear W28934703182019 @default.
• W2893470318 countsByYear W28934703182020 @default.
• W2893470318 countsByYear W28934703182021 @default.
• W2893470318 countsByYear W28934703182022 @default.
• W2893470318 countsByYear W28934703182023 @default.
• W2893470318 crossrefType "journal-article" @default.
• W2893470318 hasAuthorship W2893470318A5003599279 @default.
• W2893470318 hasAuthorship W2893470318A5031530236 @default.
• W2893470318 hasAuthorship W2893470318A5054662814 @default.
• W2893470318 hasAuthorship W2893470318A5057157877 @default.
• W2893470318 hasAuthorship W2893470318A5060705275 @default.
• W2893470318 hasAuthorship W2893470318A5067726769 @default.
• W2893470318 hasAuthorship W2893470318A5086356696 @default.
• W2893470318 hasBestOaLocation W28934703181 @default.
• W2893470318 hasConcept C124490489 @default.
• W2893470318 hasConcept C126322002 @default.
• W2893470318 hasConcept C134018914 @default.
• W2893470318 hasConcept C147990577 @default.
• W2893470318 hasConcept C159641895 @default.
• W2893470318 hasConcept C201903717 @default.
• W2893470318 hasConcept C204452808 @default.
• W2893470318 hasConcept C2776997535 @default.
• W2893470318 hasConcept C2908647359 @default.
• W2893470318 hasConcept C42407357 @default.
• W2893470318 hasConcept C555293320 @default.
• W2893470318 hasConcept C71924100 @default.
• W2893470318 hasConcept C72563966 @default.
• W2893470318 hasConcept C77350462 @default.
• W2893470318 hasConcept C99454951 @default.
• W2893470318 hasConceptScore W2893470318C124490489 @default.
• W2893470318 hasConceptScore W2893470318C126322002 @default.

• next